Cargando…

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

Accumulating evidence highlights natural killer (NK) cell parameters as potential prognostic factors in cancer patients, which provides a strong rationale for developing therapeutic strategies aiming at restoring NK cell. However, reaching this point warrants better characterization of tumor-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Galseran, Claire, Rey, Jerome, Bouvier Borg, Gaelle, Gautherot, Emmanuel, Granjeaud, Samuel, Hamel-Broza, Jean-François, Demerle, Clemence, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Gregori, Emilie, Luche, Herve, Malissen, Marie, Arnoulet, Christine, Nunes, Jacques A., Vey, Norbert, Olive, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447002/ https://www.ncbi.nlm.nih.gov/pubmed/28611767 http://dx.doi.org/10.3389/fimmu.2017.00573

Ejemplares similares

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2019)

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015)

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
por: Chretien, Anne-Sophie, et al.
Publicado: (2021)

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
por: Le Roy, Aude, et al.
Publicado: (2018)

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
por: Chretien, Anne-Sophie, et al.
Publicado: (2014)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells
por: Rey, Jérôme, et al.
Publicado: (2017)

High-throughput mass cytometry staining for deep phenotyping of human natural killer cells
por: Ben Amara, Amira, et al.
Publicado: (2022)

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
por: Demerlé, Clémence, et al.
Publicado: (2023)

Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells
por: Le Floch, Anne-Charlotte, et al.
Publicado: (2023)

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
por: Dulphy, Nicolas, et al.
Publicado: (2016)

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
por: Demerlé, Clemence, et al.
Publicado: (2021)

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma
por: Malissen, Nausicaa, et al.
Publicado: (2019)

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation
por: Gertner-Dardenne, Julie, et al.
Publicado: (2013)

Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes
por: Gon, Stéphanie, et al.
Publicado: (2018)

Mixed Streptococcus pneumoniae and Streptococcus pyogenes meningitis in an immunocompromised adult patient: a case report
por: Demerle, Clémence, et al.
Publicado: (2015)

Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia
por: Vey, Norbert
Publicado: (2020)

In response to Mayte Bryce-Alberti's letter about “Factors influencing medical students’ choice of specialization: A gender based systematic review”
por: LEVAILLANT, Mathieu, et al.
Publicado: (2021)

Downregulation of stromal syntenin sustains AML development
por: Leblanc, Raphael, et al.
Publicado: (2023)

Single‐cell transcriptomics uncovers an instructive T‐cell receptor role in adult γδ T‐cell lineage commitment
por: Scaramuzzino, Sara, et al.
Publicado: (2022)

SNP-array lesions in core binding factor acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer
por: Karkeni, Esma, et al.
Publicado: (2019)

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2008)

Apprentissage et utilisation du BUS IEEE 488/CEI 625
por: Vey, Jean Jacques
Publicado: (1985)

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
por: Devillier, Raynier, et al.
Publicado: (2015)

Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice
por: Ricard, Clément, et al.
Publicado: (2016)

Factors influencing medical students’ choice of specialization: A gender based systematic review
por: Levaillant, Mathieu, et al.
Publicado: (2020)

Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock
por: Carvelli, Julien, et al.
Publicado: (2019)

Screening platelet function in blood donors
por: Pedini, Pascal, et al.
Publicado: (2022)

Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome
por: Ittel, Antoine, et al.
Publicado: (2021)

Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples
por: de la Blétière, Diane Raingeard, et al.
Publicado: (2012)

Targeting regulated cell death pathways in acute myeloid leukemia
por: Garciaz, Sylvain, et al.
Publicado: (2023)

In France, distance from hospital and health care structure impact on outcome after arthroplasty of the hip for proximal fractures of the femur
por: Levaillant, Mathieu, et al.
Publicado: (2023)

Diversity of innate immune cell subsets across spatial and temporal scales in an EAE mouse model
por: Caravagna, Céline, et al.
Publicado: (2018)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia
por: Vey, Norbert, et al.
Publicado: (2016)

MicroArray Facility: a laboratory information management system with extended support for Nylon based technologies
por: Honoré, Paul, et al.
Publicado: (2006)

Assessing the hospital volume-outcome relationship in surgery: a scoping review
por: Levaillant, Mathieu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_92d3svd6a1ca22hbn2o28369vt